

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immunoglobulin mediated immune response (GO:0016064) | 7.78592278 |
| 2 | B cell mediated immunity (GO:0019724) | 6.29810536 |
| 3 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.81413819 |
| 4 | interferon-gamma-mediated signaling pathway (GO:0060333) | 5.80112475 |
| 5 | positive regulation of antigen processing and presentation (GO:0002579) | 5.52457326 |
| 6 | regulation of antigen processing and presentation (GO:0002577) | 5.37426708 |
| 7 | positive thymic T cell selection (GO:0045059) | 4.87893240 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.47665109 |
| 9 | cellular response to interferon-gamma (GO:0071346) | 4.44765229 |
| 10 | T cell costimulation (GO:0031295) | 4.32803406 |
| 11 | lymphocyte costimulation (GO:0031294) | 4.27333212 |
| 12 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.24058440 |
| 13 | detection of bacterium (GO:0016045) | 4.09849179 |
| 14 | negative regulation of B cell apoptotic process (GO:0002903) | 4.05472847 |
| 15 | production of molecular mediator of immune response (GO:0002440) | 4.05230114 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.89056564 |
| 17 | response to interferon-gamma (GO:0034341) | 3.88587655 |
| 18 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.86969707 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 3.85104766 |
| 20 | detection of other organism (GO:0098543) | 3.78834559 |
| 21 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.72728638 |
| 22 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.71513143 |
| 23 | regulation of B cell apoptotic process (GO:0002902) | 3.70279861 |
| 24 | positive T cell selection (GO:0043368) | 3.69195728 |
| 25 | mast cell activation (GO:0045576) | 3.68842324 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.68815362 |
| 27 | DNA deamination (GO:0045006) | 3.65242745 |
| 28 | regulation of germinal center formation (GO:0002634) | 3.64282440 |
| 29 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.62642238 |
| 30 | growth hormone receptor signaling pathway (GO:0060396) | 3.58449163 |
| 31 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.48550825 |
| 32 | positive regulation of type 2 immune response (GO:0002830) | 3.46241762 |
| 33 | T-helper 1 type immune response (GO:0042088) | 3.45249353 |
| 34 | negative regulation of mast cell activation (GO:0033004) | 3.44145699 |
| 35 | regulation of hypersensitivity (GO:0002883) | 3.40683938 |
| 36 | T cell receptor signaling pathway (GO:0050852) | 3.38731476 |
| 37 | mature B cell differentiation involved in immune response (GO:0002313) | 3.35348531 |
| 38 | response to interferon-beta (GO:0035456) | 3.32797394 |
| 39 | positive regulation of macrophage cytokine production (GO:0060907) | 3.30792461 |
| 40 | cellular response to growth hormone stimulus (GO:0071378) | 3.20268230 |
| 41 | cell wall macromolecule metabolic process (GO:0044036) | 3.19721167 |
| 42 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.19041981 |
| 43 | mast cell activation involved in immune response (GO:0002279) | 3.17730456 |
| 44 | mast cell degranulation (GO:0043303) | 3.17730456 |
| 45 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.17688090 |
| 46 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.17307318 |
| 47 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.14277518 |
| 48 | regulation of mast cell activation (GO:0033003) | 3.13519036 |
| 49 | response to peptidoglycan (GO:0032494) | 3.07411371 |
| 50 | B cell receptor signaling pathway (GO:0050853) | 2.98804852 |
| 51 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.97811423 |
| 52 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.96531437 |
| 53 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.94662224 |
| 54 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.94352956 |
| 55 | negative thymic T cell selection (GO:0045060) | 2.93441271 |
| 56 | tryptophan metabolic process (GO:0006568) | 2.92268264 |
| 57 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.92251680 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.91567664 |
| 59 | positive regulation of prostaglandin secretion (GO:0032308) | 2.91146666 |
| 60 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.89491942 |
| 61 | mature B cell differentiation (GO:0002335) | 2.87826046 |
| 62 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.85744318 |
| 63 | detection of external biotic stimulus (GO:0098581) | 2.82550195 |
| 64 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.76794224 |
| 65 | negative T cell selection (GO:0043383) | 2.75751727 |
| 66 | positive regulation of interferon-gamma production (GO:0032729) | 2.74244487 |
| 67 | positive regulation of T cell activation (GO:0050870) | 2.74080085 |
| 68 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.73586052 |
| 69 | cell wall macromolecule catabolic process (GO:0016998) | 2.71003670 |
| 70 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.69684671 |
| 71 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.68238526 |
| 72 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.67503033 |
| 73 | response to muramyl dipeptide (GO:0032495) | 2.66234479 |
| 74 | positive regulation of mast cell activation (GO:0033005) | 2.65925682 |
| 75 | myeloid cell activation involved in immune response (GO:0002275) | 2.65620822 |
| 76 | positive regulation of B cell proliferation (GO:0030890) | 2.64139706 |
| 77 | indole-containing compound catabolic process (GO:0042436) | 2.63241591 |
| 78 | indolalkylamine catabolic process (GO:0046218) | 2.63241591 |
| 79 | tryptophan catabolic process (GO:0006569) | 2.63241591 |
| 80 | positive regulation of B cell differentiation (GO:0045579) | 2.62387974 |
| 81 | detection of biotic stimulus (GO:0009595) | 2.61395178 |
| 82 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.61023815 |
| 83 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.60716313 |
| 84 | leukocyte degranulation (GO:0043299) | 2.60385874 |
| 85 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.59834479 |
| 86 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.59520060 |
| 87 | positive regulation of T cell proliferation (GO:0042102) | 2.59475138 |
| 88 | regulation of T-helper 1 type immune response (GO:0002825) | 2.58674892 |
| 89 | adaptive immune response (GO:0002250) | 2.57861951 |
| 90 | thymic T cell selection (GO:0045061) | 2.57828285 |
| 91 | positive regulation of mast cell degranulation (GO:0043306) | 2.56216091 |
| 92 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.56216091 |
| 93 | antigen processing and presentation of peptide antigen via MHC class II (GO:0002495) | 2.56149088 |
| 94 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:000250 | 2.56149088 |
| 95 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.55491936 |
| 96 | positive regulation of interleukin-17 production (GO:0032740) | 2.54721160 |
| 97 | antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886) | 2.54165360 |
| 98 | T cell selection (GO:0045058) | 2.52178144 |
| 99 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.49992989 |
| 100 | actin nucleation (GO:0045010) | 2.49991946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.48731293 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.65043047 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.72275258 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.88217197 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.70102503 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.67232249 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.24005566 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.20947320 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.88673317 |
| 10 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.73011702 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.70619452 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.54545194 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.51601418 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.23233950 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.22037292 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.18914007 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.01410993 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.92362126 |
| 19 | GATA3_26560356_Chip-Seq_TH2_Human | 1.91756217 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.87682508 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.81748085 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81092521 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.80200599 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79309381 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79221732 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.72084665 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60203884 |
| 28 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.60036383 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58230318 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56680954 |
| 31 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56436396 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50256454 |
| 33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.47987623 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.46477252 |
| 35 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.44976842 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.41358528 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39823910 |
| 38 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.39706119 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35978236 |
| 40 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33342188 |
| 41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33075786 |
| 42 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.32995997 |
| 43 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.32707033 |
| 44 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.30582641 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30542896 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.26085094 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25427167 |
| 48 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.24885419 |
| 49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24709585 |
| 50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24123508 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23748381 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21263023 |
| 53 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.19869210 |
| 54 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.19869210 |
| 55 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.19485348 |
| 56 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19144908 |
| 57 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.19120842 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.18704481 |
| 59 | AR_20517297_ChIP-Seq_VCAP_Human | 1.18516073 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17397158 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15109643 |
| 62 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.12611164 |
| 63 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12312977 |
| 64 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12312977 |
| 65 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.10741373 |
| 66 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.09965049 |
| 67 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07975112 |
| 68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07962155 |
| 69 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06321545 |
| 70 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.05808542 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05801326 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03324921 |
| 73 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.03306678 |
| 74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01253986 |
| 75 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.00829253 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00066727 |
| 77 | GATA3_26560356_Chip-Seq_TH1_Human | 0.98227551 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97054012 |
| 79 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96992293 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95080136 |
| 81 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.92638003 |
| 82 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92589286 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92221101 |
| 84 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.91673709 |
| 85 | MAF_26560356_Chip-Seq_TH1_Human | 0.91480838 |
| 86 | P300_27268052_Chip-Seq_Bcells_Human | 0.91046706 |
| 87 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.90883517 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89997668 |
| 89 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89314141 |
| 90 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.88965142 |
| 91 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88697861 |
| 92 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.88696015 |
| 93 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87622920 |
| 94 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.86494249 |
| 95 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84310665 |
| 96 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.83687529 |
| 97 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.82328125 |
| 98 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.81894097 |
| 99 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.81478346 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81403520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.57529890 |
| 2 | MP0002138_abnormal_hepatobiliary_system | 4.72486778 |
| 3 | MP0003724_increased_susceptibility_to | 3.70890526 |
| 4 | MP0005671_abnormal_response_to | 3.42404776 |
| 5 | MP0001800_abnormal_humoral_immune | 3.08629579 |
| 6 | MP0000685_abnormal_immune_system | 2.91157899 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.84486488 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.84410290 |
| 9 | MP0009785_altered_susceptibility_to | 2.84203468 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.80151875 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.56061075 |
| 12 | MP0003436_decreased_susceptibility_to | 2.49270459 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.46924707 |
| 14 | MP0002723_abnormal_immune_serum | 2.36031449 |
| 15 | MP0001790_abnormal_immune_system | 2.32202688 |
| 16 | MP0005387_immune_system_phenotype | 2.32202688 |
| 17 | MP0002006_tumorigenesis | 2.23243735 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.11132054 |
| 19 | MP0001819_abnormal_immune_cell | 2.09165120 |
| 20 | MP0002419_abnormal_innate_immunity | 2.01387727 |
| 21 | MP0005025_abnormal_response_to | 1.98141302 |
| 22 | MP0009764_decreased_sensitivity_to | 1.96799606 |
| 23 | MP0010155_abnormal_intestine_physiology | 1.83735662 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 1.79556391 |
| 25 | MP0001545_abnormal_hematopoietic_system | 1.79556391 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.76225414 |
| 27 | MP0005075_abnormal_melanosome_morpholog | 1.73495232 |
| 28 | MP0002398_abnormal_bone_marrow | 1.64670639 |
| 29 | MP0000716_abnormal_immune_system | 1.63273357 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.62948461 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.59662029 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.59147633 |
| 33 | MP0005645_abnormal_hypothalamus_physiol | 1.50846126 |
| 34 | MP0009278_abnormal_bone_marrow | 1.48793842 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.48232569 |
| 36 | MP0003866_abnormal_defecation | 1.47693752 |
| 37 | MP0008872_abnormal_physiological_respon | 1.46725076 |
| 38 | MP0004147_increased_porphyrin_level | 1.46003433 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.40314976 |
| 40 | MP0001853_heart_inflammation | 1.39293125 |
| 41 | MP0006054_spinal_hemorrhage | 1.36523263 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.36284994 |
| 43 | MP0003075_altered_response_to | 1.32915157 |
| 44 | MP0002429_abnormal_blood_cell | 1.30888985 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.30460559 |
| 46 | MP0003303_peritoneal_inflammation | 1.30405925 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.28994090 |
| 48 | MP0002139_abnormal_hepatobiliary_system | 1.25631626 |
| 49 | MP0008469_abnormal_protein_level | 1.24972551 |
| 50 | MP0005367_renal/urinary_system_phenotyp | 1.23168779 |
| 51 | MP0000516_abnormal_urinary_system | 1.23168779 |
| 52 | MP0002405_respiratory_system_inflammati | 1.21856360 |
| 53 | MP0006082_CNS_inflammation | 1.21447894 |
| 54 | MP0003646_muscle_fatigue | 1.20023972 |
| 55 | MP0000569_abnormal_digit_pigmentation | 1.18819133 |
| 56 | MP0003763_abnormal_thymus_physiology | 1.16352782 |
| 57 | MP0002722_abnormal_immune_system | 1.11893931 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.08126986 |
| 59 | MP0004145_abnormal_muscle_electrophysio | 1.06488562 |
| 60 | MP0005166_decreased_susceptibility_to | 1.06402416 |
| 61 | MP0004947_skin_inflammation | 1.05523341 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.05190244 |
| 63 | MP0000013_abnormal_adipose_tissue | 1.01230013 |
| 64 | MP0005360_urolithiasis | 1.00142031 |
| 65 | MP0009643_abnormal_urine_homeostasis | 0.95461535 |
| 66 | MP0002396_abnormal_hematopoietic_system | 0.94488193 |
| 67 | MP0005085_abnormal_gallbladder_physiolo | 0.90836832 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 0.90306416 |
| 69 | MP0001873_stomach_inflammation | 0.89473441 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.86788806 |
| 71 | MP0005646_abnormal_pituitary_gland | 0.85665238 |
| 72 | MP0002132_abnormal_respiratory_system | 0.85078536 |
| 73 | MP0000858_altered_metastatic_potential | 0.82692029 |
| 74 | MP0005165_increased_susceptibility_to | 0.78380095 |
| 75 | MP0003252_abnormal_bile_duct | 0.76432736 |
| 76 | MP0003300_gastrointestinal_ulcer | 0.75864720 |
| 77 | MP0002019_abnormal_tumor_incidence | 0.75681236 |
| 78 | MP0000372_irregular_coat_pigmentation | 0.73099645 |
| 79 | MP0009763_increased_sensitivity_to | 0.72489745 |
| 80 | MP0005410_abnormal_fertilization | 0.68170081 |
| 81 | MP0003186_abnormal_redox_activity | 0.67761570 |
| 82 | MP0000249_abnormal_blood_vessel | 0.67440896 |
| 83 | MP0005220_abnormal_exocrine_pancreas | 0.66576748 |
| 84 | MP0005332_abnormal_amino_acid | 0.66298536 |
| 85 | MP0005535_abnormal_body_temperature | 0.66136783 |
| 86 | MP0004808_abnormal_hematopoietic_stem | 0.65406105 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.65207094 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 0.65029740 |
| 89 | MP0005174_abnormal_tail_pigmentation | 0.64925371 |
| 90 | MP0004043_abnormal_pH_regulation | 0.64861269 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.63976109 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.63734568 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.62930201 |
| 94 | MP0001968_abnormal_touch/_nociception | 0.62489379 |
| 95 | MP0008873_increased_physiological_sensi | 0.59372687 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 0.59243545 |
| 97 | MP0001542_abnormal_bone_strength | 0.56287209 |
| 98 | MP0001501_abnormal_sleep_pattern | 0.55869420 |
| 99 | MP0005390_skeleton_phenotype | 0.55687478 |
| 100 | MP0005636_abnormal_mineral_homeostasis | 0.55205791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.96494610 |
| 2 | Abnormality of the prostate (HP:0008775) | 4.99421707 |
| 3 | Meningitis (HP:0001287) | 3.76251566 |
| 4 | Agammaglobulinemia (HP:0004432) | 3.70431146 |
| 5 | Chest pain (HP:0100749) | 3.53097827 |
| 6 | Vasculitis (HP:0002633) | 3.51983649 |
| 7 | Gastrointestinal infarctions (HP:0005244) | 3.45990502 |
| 8 | Panhypogammaglobulinemia (HP:0003139) | 3.44700020 |
| 9 | Pulmonary infiltrates (HP:0002113) | 3.31141650 |
| 10 | Myositis (HP:0100614) | 3.29239922 |
| 11 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.22325464 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.11365771 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.07837835 |
| 14 | Prostate neoplasm (HP:0100787) | 3.05301231 |
| 15 | Abnormality of the pleura (HP:0002103) | 3.04931482 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 2.97171793 |
| 17 | Obstructive lung disease (HP:0006536) | 2.97171793 |
| 18 | Optic neuritis (HP:0100653) | 2.93148200 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 2.93148200 |
| 20 | Exertional dyspnea (HP:0002875) | 2.90073886 |
| 21 | Urticaria (HP:0001025) | 2.87718385 |
| 22 | Abnormality of male internal genitalia (HP:0000022) | 2.85721352 |
| 23 | Hemoptysis (HP:0002105) | 2.82563345 |
| 24 | Congenital, generalized hypertrichosis (HP:0004540) | 2.78218538 |
| 25 | Orchitis (HP:0100796) | 2.73234249 |
| 26 | Pulmonary fibrosis (HP:0002206) | 2.72019812 |
| 27 | Gangrene (HP:0100758) | 2.62321552 |
| 28 | Arterial thrombosis (HP:0004420) | 2.59844405 |
| 29 | Hepatocellular necrosis (HP:0001404) | 2.59007797 |
| 30 | Pulmonary embolism (HP:0002204) | 2.58343559 |
| 31 | Decreased central vision (HP:0007663) | 2.55217274 |
| 32 | Hepatic necrosis (HP:0002605) | 2.54076551 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 2.53420402 |
| 34 | Alveolar cell carcinoma (HP:0006519) | 2.52023626 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.49168263 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 2.49168263 |
| 37 | Type 2 muscle fiber atrophy (HP:0003554) | 2.48549455 |
| 38 | Encephalitis (HP:0002383) | 2.45717569 |
| 39 | Acute hepatic failure (HP:0006554) | 2.45558869 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.43663943 |
| 41 | Abnormality of B cell number (HP:0010975) | 2.43448573 |
| 42 | IgG deficiency (HP:0004315) | 2.42970205 |
| 43 | Abnormality of T cell physiology (HP:0011840) | 2.41905548 |
| 44 | Ureteral obstruction (HP:0006000) | 2.40349117 |
| 45 | Ureteral stenosis (HP:0000071) | 2.39667118 |
| 46 | Increased intramyocellular lipid droplets (HP:0012240) | 2.38614927 |
| 47 | Recurrent fungal infections (HP:0002841) | 2.38590884 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.38051395 |
| 49 | Mitochondrial inheritance (HP:0001427) | 2.35436422 |
| 50 | Increased hepatocellular lipid droplets (HP:0006565) | 2.34653276 |
| 51 | Skin rash (HP:0000988) | 2.32832504 |
| 52 | Hypoproteinemia (HP:0003075) | 2.31683333 |
| 53 | Stomatitis (HP:0010280) | 2.31170647 |
| 54 | Amaurosis fugax (HP:0100576) | 2.30026169 |
| 55 | 3-Methylglutaconic aciduria (HP:0003535) | 2.29142917 |
| 56 | Chronic otitis media (HP:0000389) | 2.28355157 |
| 57 | Abolished electroretinogram (ERG) (HP:0000550) | 2.28151499 |
| 58 | IgM deficiency (HP:0002850) | 2.28003245 |
| 59 | Increased CSF lactate (HP:0002490) | 2.25488972 |
| 60 | Abnormality of the peritoneum (HP:0002585) | 2.25284963 |
| 61 | Recurrent sinusitis (HP:0011108) | 2.24261806 |
| 62 | Fatigue (HP:0012378) | 2.23288992 |
| 63 | Stomach cancer (HP:0012126) | 2.21614937 |
| 64 | Lipid accumulation in hepatocytes (HP:0006561) | 2.18876653 |
| 65 | Hypothermia (HP:0002045) | 2.18050210 |
| 66 | Chronic diarrhea (HP:0002028) | 2.17152621 |
| 67 | Dry hair (HP:0011359) | 2.16832920 |
| 68 | Xerostomia (HP:0000217) | 2.15023832 |
| 69 | Recurrent bronchitis (HP:0002837) | 2.14618894 |
| 70 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.10730145 |
| 71 | Recurrent skin infections (HP:0001581) | 2.10271650 |
| 72 | Chronic sinusitis (HP:0011109) | 2.10039643 |
| 73 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.09563472 |
| 74 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.09563472 |
| 75 | Abnormality of T cells (HP:0002843) | 2.09511825 |
| 76 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.07388374 |
| 77 | Acute necrotizing encephalopathy (HP:0006965) | 2.06939928 |
| 78 | Increased muscle lipid content (HP:0009058) | 2.02040973 |
| 79 | Muscle fiber atrophy (HP:0100295) | 2.01212238 |
| 80 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.00246330 |
| 81 | Congenital stationary night blindness (HP:0007642) | 1.99256564 |
| 82 | Thrombophlebitis (HP:0004418) | 1.98889001 |
| 83 | Facial diplegia (HP:0001349) | 1.98522987 |
| 84 | Cerebral ischemia (HP:0002637) | 1.98424908 |
| 85 | Cerebral hemorrhage (HP:0001342) | 1.98186566 |
| 86 | Progressive macrocephaly (HP:0004481) | 1.97781084 |
| 87 | Polyneuropathy (HP:0001271) | 1.96903856 |
| 88 | Recurrent viral infections (HP:0004429) | 1.94287889 |
| 89 | Increased cerebral lipofuscin (HP:0011813) | 1.93464750 |
| 90 | Keratoconjunctivitis sicca (HP:0001097) | 1.93353855 |
| 91 | Petechiae (HP:0000967) | 1.92286562 |
| 92 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.91485582 |
| 93 | Glomerulopathy (HP:0100820) | 1.89600607 |
| 94 | Lactic acidosis (HP:0003128) | 1.89229973 |
| 95 | Increased serum lactate (HP:0002151) | 1.89073035 |
| 96 | Restrictive lung disease (HP:0002091) | 1.86776991 |
| 97 | B lymphocytopenia (HP:0010976) | 1.85855677 |
| 98 | Gastrointestinal stroma tumor (HP:0100723) | 1.85590838 |
| 99 | Amyloidosis (HP:0011034) | 1.84804596 |
| 100 | Keratoconjunctivitis (HP:0001096) | 1.83223258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.11712057 |
| 2 | BMPR2 | 3.92042600 |
| 3 | TLK1 | 3.87449384 |
| 4 | KIT | 3.28983359 |
| 5 | CDK19 | 3.14208166 |
| 6 | ZAK | 2.72576403 |
| 7 | MAP4K1 | 2.51224533 |
| 8 | BCKDK | 2.37456485 |
| 9 | CDK8 | 2.35502121 |
| 10 | MAP3K14 | 2.30095605 |
| 11 | CSF1R | 2.22500610 |
| 12 | JAK3 | 2.10909838 |
| 13 | MAP4K2 | 1.99136365 |
| 14 | SYK | 1.97914220 |
| 15 | RIPK4 | 1.96598500 |
| 16 | BMPR1B | 1.92029954 |
| 17 | IKBKB | 1.91092770 |
| 18 | FRK | 1.89092147 |
| 19 | TEC | 1.85632258 |
| 20 | MST4 | 1.80811306 |
| 21 | TXK | 1.74488990 |
| 22 | FES | 1.68259355 |
| 23 | EIF2AK3 | 1.58807212 |
| 24 | TBK1 | 1.56107231 |
| 25 | FLT3 | 1.53248401 |
| 26 | IKBKE | 1.51790658 |
| 27 | BTK | 1.51727889 |
| 28 | TRPM7 | 1.49771258 |
| 29 | OXSR1 | 1.48389180 |
| 30 | PIK3CG | 1.47926011 |
| 31 | VRK1 | 1.47021846 |
| 32 | TIE1 | 1.43734942 |
| 33 | KDR | 1.38825204 |
| 34 | ITK | 1.36071534 |
| 35 | GRK1 | 1.33415226 |
| 36 | NUAK1 | 1.33032032 |
| 37 | LYN | 1.28026020 |
| 38 | ADRBK2 | 1.26780631 |
| 39 | ERBB3 | 1.22883266 |
| 40 | VRK2 | 1.21966765 |
| 41 | MAP3K13 | 1.12838704 |
| 42 | IRAK4 | 1.11370574 |
| 43 | GRK6 | 1.10240084 |
| 44 | SCYL2 | 1.00217933 |
| 45 | BLK | 0.99104139 |
| 46 | RPS6KA5 | 0.97785992 |
| 47 | TGFBR1 | 0.96674106 |
| 48 | LCK | 0.95733962 |
| 49 | MAP3K12 | 0.91935912 |
| 50 | HCK | 0.88756635 |
| 51 | CHUK | 0.86827762 |
| 52 | MAPKAPK5 | 0.84568665 |
| 53 | MAPKAPK3 | 0.84213005 |
| 54 | DAPK3 | 0.84096809 |
| 55 | PINK1 | 0.75517213 |
| 56 | TYK2 | 0.75043018 |
| 57 | WNK4 | 0.74558867 |
| 58 | CSNK1G3 | 0.74549455 |
| 59 | ABL1 | 0.72121459 |
| 60 | MAP2K2 | 0.67215007 |
| 61 | DAPK1 | 0.65252078 |
| 62 | MKNK1 | 0.63888130 |
| 63 | JAK1 | 0.60209677 |
| 64 | IGF1R | 0.60200889 |
| 65 | PRKCQ | 0.55566295 |
| 66 | EGFR | 0.54659304 |
| 67 | ZAP70 | 0.52248792 |
| 68 | EIF2AK2 | 0.52147156 |
| 69 | MATK | 0.51911078 |
| 70 | CSNK1G2 | 0.51876534 |
| 71 | CCNB1 | 0.50269271 |
| 72 | JAK2 | 0.48151580 |
| 73 | PIM1 | 0.47038028 |
| 74 | MARK3 | 0.46920520 |
| 75 | TNK2 | 0.44703958 |
| 76 | INSRR | 0.44676709 |
| 77 | CSNK1A1L | 0.43670646 |
| 78 | MYLK | 0.43174172 |
| 79 | NME2 | 0.41828473 |
| 80 | TAF1 | 0.41762528 |
| 81 | PRKCD | 0.39475599 |
| 82 | SIK3 | 0.37000630 |
| 83 | CDK9 | 0.36299270 |
| 84 | MAP3K6 | 0.34923393 |
| 85 | GRK7 | 0.33943144 |
| 86 | PDK1 | 0.33329138 |
| 87 | CSNK1G1 | 0.33006410 |
| 88 | PHKG1 | 0.31898633 |
| 89 | PHKG2 | 0.31898633 |
| 90 | MAPK7 | 0.31867649 |
| 91 | CSK | 0.31717791 |
| 92 | PLK2 | 0.29996774 |
| 93 | ADRBK1 | 0.29569658 |
| 94 | DAPK2 | 0.28728937 |
| 95 | GRK5 | 0.27606459 |
| 96 | ERN1 | 0.26971623 |
| 97 | RPS6KB2 | 0.26914075 |
| 98 | STK38L | 0.26517395 |
| 99 | PKN1 | 0.26397864 |
| 100 | MAPK11 | 0.23578579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 6.30802753 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 5.34182620 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 5.03956335 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.96667291 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.76434945 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.35475644 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.19371823 |
| 8 | Viral myocarditis_Homo sapiens_hsa05416 | 3.05114895 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.02925620 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.97057870 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85051935 |
| 12 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.62329040 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.31332567 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43220399 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.42158049 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34812737 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30738492 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24572586 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.23978858 |
| 20 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.16885760 |
| 21 | Proteasome_Homo sapiens_hsa03050 | 1.15863995 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 0.93399431 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.87846104 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85598393 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 0.80686675 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75866624 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73434727 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.73250972 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 0.69168383 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67013533 |
| 31 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62921757 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62644763 |
| 33 | Alcoholism_Homo sapiens_hsa05034 | 0.60288994 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58292476 |
| 35 | Ribosome_Homo sapiens_hsa03010 | 0.57555373 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53890660 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50644835 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48179795 |
| 39 | Protein export_Homo sapiens_hsa03060 | 0.43129198 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 0.42760379 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40832334 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40226423 |
| 43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39118069 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37014501 |
| 45 | RNA degradation_Homo sapiens_hsa03018 | 0.36250976 |
| 46 | Homologous recombination_Homo sapiens_hsa03440 | 0.35383175 |
| 47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.35155645 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.34990948 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34194413 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33252715 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.32063724 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31689579 |
| 53 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30607817 |
| 54 | Measles_Homo sapiens_hsa05162 | 0.30507793 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.30344934 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.29391965 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29345189 |
| 58 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28115227 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.25585848 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.25032512 |
| 61 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24095401 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.23102734 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.20829259 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.19328389 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.19177079 |
| 66 | Shigellosis_Homo sapiens_hsa05131 | 0.18505312 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.18300983 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.18292749 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.17427801 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.17343713 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.16582868 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.16367443 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.15977751 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.15825995 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.15471220 |
| 76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.14413519 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.13722965 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.12512559 |
| 79 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.12149037 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.11833268 |
| 81 | RNA polymerase_Homo sapiens_hsa03020 | 0.08649283 |
| 82 | Purine metabolism_Homo sapiens_hsa00230 | 0.08380212 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.07435482 |
| 84 | Salivary secretion_Homo sapiens_hsa04970 | 0.07085264 |
| 85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.06718266 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.06717000 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.06307366 |
| 88 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.06245032 |
| 89 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.04992434 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.04819092 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.04527784 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.03868753 |
| 93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.02877610 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.02674081 |
| 95 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.02612585 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.01785960 |
| 97 | Basal transcription factors_Homo sapiens_hsa03022 | 0.01647782 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.01132493 |
| 99 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0174819 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | -0.0038409 |

